Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Thursday, shares of Saia Inc ( SAIA - Get Report) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $23.59 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 53.9. A bullish investor could look at SAIA's 29.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of SAIA shares: Looking at the chart above, SAIA's low point in its 52 week range is $22.64 per share, with $57.60 as the 52 week high point — that compares with a last trade of $23.68. According to the ETF Finder at ETF Channel, SAIA makes up 1.11% of the SPDR S&P Transportation ETF ( XTN) which is trading lower by about 0.3% on the day Thursday.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
What Every Investor Needs to Know: Cramer's 'Mad Money' Recap (Monday 6/24/19)
Jim Cramer explains the ins and outs of essential economic and investing lessons that every stock investor needs to know.
The Weak Dollar Is the Main Force in the Market Right Now
Gold continues to run higher as the dollar continues to collapse.
Stocks End Mixed as Wall Street Looks to G-20 Summit for U.S.-China Trade Talks
Stocks end little changed Monday as investors look to the upcoming G-20 summit for a breakthrough in talks between the world's two largest economies.
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
About 6 million women suffer from hypoactive sexual desire disorder, which Palatin's Vyleesi is designed to treat.